MAR 06, 2018 1:02 PM PST

Diagnosing and Treating An Extremely Rare Genetic Disease: Progeria

WRITTEN BY: Kara Marker

An extremely rare genetic disease that causes accelerated aging and heart disease has been little studied, largely due to a lack of relevant animal models. But now, scientists from the Centro Nacional de Investigaciones Cardiovasculares introduce the first mice genetically modified to illustrate atherosclerosis in the context of this rare disease, progeria, also known as Hutchinson-Gilford syndrome (HGPS).

In HGPS patients the cell nucleus has dramatically aberrant morphology (bottom, right) rather than the uniform shape typically found in healthy individuals (top, right). Credit: The Cell Nucleus and Aging: Tantalizing Clues and Hopeful Promises. Scaffidi P, Gordon L, Misteli T. PLoS Biology Vol. 3/11/2005, e395

Less than 400 people in the entire world have progeria. The disease is caused by a mutation in the LMNA gene, which produces a protein called Lamin A. This is a protein responsible for providing a foundation for holding a cell’s nucleus together. When Lamin A production is disrupted, the nucleus becomes unstable, which leads to premature aging characteristic of progeria. There is no effective treatment for this rare disease.

In addition to losing hair and body fat, osteoporosis, joint stiffness and wrinkled skin, progeria is characterized by atherosclerosis, a form of heart disease where plaques develop in the blood vessels and prevent healthy blood flow. When plaques rupture, heart attack or stroke can occur. Those affected by progeria rarely make it to their 15th birthday, and heart attack or stroke from ruptured atherosclerotic lesions is almost always the reason why.

But thanks to the new mice model of progeria, scientists can study the disease on a closer level than ever. For example researchers found that changes in the smooth muscle cell lining of blood vessels is largely responsible for atherosclerosis and premature aging in cases of progeria. Atherosclerosis is also triggered by progerin, a shortened version of the lamin A protein responsible for the disease. Cardiovascular deterioration and aging worsened by the accumulation of progerin.

"We found that smooth muscle cells in the arterial wall die early in the development of disease in the progeroid mice, and this induces an anomalous accumulation of lipoproteins in the vessels,” explained first author Dr. Magda Hamczyk. “This significantly increases the formation of atherosclerotic plaques, and the loss of smooth muscle also destabilizes the plaques and promotes plaque rupture in more advanced stages."

The new findings indicate smooth muscle cells from the lining of blood vessels as a possible therapeutic target for atherosclerosis in the context of progeria. Additionally, mice only expressed progerin in specific tissues linked to atherosclerosis, which might help scientists focus on where in the body progeria develops.

"This new animal model is allowing us to advance knowledge of the molecular and cellular mechanisms that cause cardiovascular disease and accelerated aging in progeria, an indispensable goal for the development of new therapies for patients with this severe disease," said Dr. Vicente Andrews. "Research into progeria can therefore help to identify mechanisms underlying normal aging and promote a healthier old age."

The present study was published in the journal Circulation.

Sources: Progeria Research Foundation, American Heart Association, Centro Nacional de Investigaciones Cardiovasculares

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 24, 2020
Clinical & Molecular DX
Software Flags Elevated Cerebral Palsy Risk in Premies
OCT 24, 2020
Software Flags Elevated Cerebral Palsy Risk in Premies
Diagnostic imaging scientists have developed a software tool for predicting the future onset of cerebral palsy in babies ...
DEC 03, 2020
Clinical & Molecular DX
Spit Contains Concussion Clues
DEC 03, 2020
Spit Contains Concussion Clues
Drowsiness, confusion, headaches, and sensitivity to light — it’s sometimes hard for doctors to spot the sig ...
DEC 23, 2020
Cancer
A Combination of Photo and Sonodynamic Therapies Could Assist in Treating Brain Cancer
DEC 23, 2020
A Combination of Photo and Sonodynamic Therapies Could Assist in Treating Brain Cancer
Brain cancer is an incredible challenge for modern medicine. Most drugs don’t make it past the blood-brain barrier ...
JAN 19, 2021
Cardiology
Looking to the Immune System for Help Diagnosing Carotid Stenosis
JAN 19, 2021
Looking to the Immune System for Help Diagnosing Carotid Stenosis
Everyone has seen a commercial about how bad fats can build up into a plaque into a blood vessel. This is called atheros ...
FEB 11, 2021
Clinical & Molecular DX
Smartwatches Keep a Close Eye on Parkinson's Patients
FEB 11, 2021
Smartwatches Keep a Close Eye on Parkinson's Patients
Individuals with Parkinson’s disease experience a slow, progressive worsening of symptoms. What can begin as barel ...
FEB 16, 2021
Genetics & Genomics
Genetic Tests That Look for Rare, Disease-Causing Variants are Usually Wrong
FEB 16, 2021
Genetic Tests That Look for Rare, Disease-Causing Variants are Usually Wrong
While people carry mostly the same genes, there are small differences in the sequences of those genes that can have prof ...
Loading Comments...